Conferences

ASCO NEWS OF THE DAY: Monday June 4, 2018 Press Briefing

By ONA Editor June 5, 2018 No Comments

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Leave A Reply Cancel Reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Subscribe for News Updates
Search Oncology News
Search for:
Speak your mind!

Passionate about a development that deserves more attention? Views on a controversial issue?

Oncology News publishes commentary pieces from oncology professionals here and in The Oncology Newsletter.

Contact us to discuss
Subscribe for News Updates

The Oncology Newsletter is a free publication distributed to healthcare professionals every week, featuring news, views, reviews and the latest jobs. Subscribe.
About Us

Oncology News Australia is a small group of publishing, media and digital professionals providing resources for the oncology community. More information.
Advertising with Us

If you seek to connect and present your product or service to an engaged oncology healthcare community, you have come to the right place. More information.

A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive

The price of a drug should be based on its therapeutic benefits – not just what the market will bear

A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive

The price of a drug should be based on its therapeutic benefits – not just what the market will bear

ASCO NEWS OF THE DAY: Monday June 4, 2018 Press Briefing

About Author

Leave A Reply Cancel Reply

A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive

The price of a drug should be based on its therapeutic benefits – not just what the market will bear

A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive

The price of a drug should be based on its therapeutic benefits – not just what the market will bear

About Author

Related Posts

My Top 3 ASCO Abstracts by Prunella Blinman

Many women with breast cancer may not need chemo, but beware misleading headlines

My Top 3 ASCO Prostate Cancer Abstracts by Ian Davis

Leave A Reply Cancel Reply